stent thromboses

Related by string. * stenting . Stents . Stenting . Stent . stented . stents . STENT : drug coated stents . stents inserted . Endeavor stent . Valiant Thoracic Stent Graft . drug coated stent . stent graft . drug eluting stent implantation . definite stent thrombosis . metallic stents . TAXUS Liberte stent / : deep venous thromboses . blood clots thromboses . thromboses . deep vein thromboses * *

Related by context. Frequent words. (Click for all words.) 66 discontinuations due 66 myocardial infarctions 66 target lesion revascularization 66 discontinuations 65 thrombotic events 65 thromboembolic events 65 target vessel revascularization 64 myocardial infarction MI 62 Adverse events 62 events SAEs 61 stent thrombosis 61 thromboembolism 60 stent restenosis 60 myocardial infarction 60 CYPHER ® Stent 59 laboratory abnormalities 59 virologic failure 59 fondaparinux 58 abciximab 58 MIs 58 coronary revascularization 58 ticagrelor 58 intracerebral hemorrhage 58 cardiac toxicity 58 events AEs 58 myocardial infarction stroke 58 stent implantation 58 unfractionated heparin 57 endarterectomy 57 composite endpoint 57 mg kg dose 57 vertebral fracture 57 postoperative complications 57 confidence interval #.#-#.# 57 enalapril 57 PLAVIX 57 acute myocardial infarction AMI 56 TAXUS 56 enoxaparin 56 Median survival 56 cytogenetic response 56 P = .# 56 TAXUS stent 56 XGEVA 56 stable angina 56 febrile neutropenia 56 hepatotoxicity 56 hypercalcemia 56 sustained virologic response 56 distant metastases 56 TORISEL 56 placebo p = 56 severe hypoglycemia 56 evaluable 56 left ventricular dysfunction 55 active comparator 55 hypomagnesemia 55 nonresponders 55 hypersensitivity reactions 55 tumor recurrence 55 angioedema 55 nonsignificant 55 evaluable patients 55 renal insufficiency 55 QT prolongation 55 plus methotrexate 55 cSSSI 55 bivalirudin 55 hypokalemia 55 infarct size 55 leukopenia 55 nesiritide 55 cardiac dysfunction 55 LVEF 55 treatment emergent adverse 55 FOLFIRI 55 Acute Coronary Syndrome 55 tumor shrinkage 54 nasopharyngitis 54 abacavir 54 cardiovascular mortality 54 bacteremia 54 median PFS 54 annualized relapse 54 peginterferon alfa 2b 54 venous thromboembolism 54 adalimumab 54 confidence interval CI 54 vertebral fractures 54 noninferiority 54 SAEs 54 ST elevation myocardial 54 Arch Intern Med 54 candesartan 54 acute coronary syndromes 54 angina pectoris 53 ipsilateral 53 seroconversion 53 HbA1c levels 53 FOLFOX 53 thrombosis

Back to home page